SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lupin informs about acquisition

29 Sep 2025 Evaluate

Pursuant to Regulation 30 read with Schedule III of the SEBI Listing Regulations, Lupin has informed that Nanomi B.V., the Netherlands (‘Nanomi’), a wholly owned subsidiary of the Company in Netherlands has entered into a definitive agreement to acquire the entire share capital of VISUfarma B.V., headquartered in Amsterdam, the Netherlands. The details required under Regulation 30 and Schedule III of SEBI Listing Regulations, read with the SEBI Master Circular dated November 11, 2024, bearing reference number SEBI/HO/CFD/PoD2/CIR/P/0155 and such other circulars as applicable (‘SEBI Master Circular’), is set at Annexure I. A Press Release along with a brief presentation are also enclosed.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2377.90 -81.85 (-3.33%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×